“William Brangham discussed more with Euan Ashley, a professor of cardiovascular medicine and genetics at Stanford University and the newly named chair of its department of medicine.” ~ learn more
“William Brangham discussed more with Euan Ashley, a professor of cardiovascular medicine and genetics at Stanford University and the newly named chair of its department of medicine.” ~ learn more
The New Yorker takes aim and fires. “In 1873, Mark Twain co-wrote the novel “The Gilded Age: A Tale of Today,” which satirized an era that was marked by inequality, greed, and moral decay but was painted in a veneer […]
The New Yorker takes aim and fires. “In 1873, Mark Twain co-wrote the novel “The Gilded Age: A Tale of Today,” which satirized an era that was marked by inequality, greed, and moral decay but was painted in a veneer […]
This is really good. “Let’s start with the good. The idea behind HSAs is a fundamentally good one. Introduced in 2003 as part of the Medicare Modernization Act (which also defined the guidelines for high deductible health plans, or HDHPs), […]
If you wondered why the NVO stock (see above) was down almost 20% yesterday, look no further. “[Its] experimental diabetes and weight-loss drug CagriSema fell short of expectations. The drug did not achieve the projected 25% average weight loss anticipated […]
The official FDA shortage is over, and compounders have 60-90 days to stop violating Eli Lilly’s patent protection. “The ruling also previews what will happen when semaglutide — the active ingredient in Novo Nordisk’s (NVO -17.43%) Ozempic and Wegovy — […]
This is really good. “Let’s start with the good. The idea behind HSAs is a fundamentally good one. Introduced in 2003 as part of the Medicare Modernization Act (which also defined the guidelines for high deductible health plans, or HDHPs), […]
If you wondered why the NVO stock (see above) was down almost 20% yesterday, look no further. “[Its] experimental diabetes and weight-loss drug CagriSema fell short of expectations. The drug did not achieve the projected 25% average weight loss anticipated […]
The official FDA shortage is over, and compounders have 60-90 days to stop violating Eli Lilly’s patent protection. “The ruling also previews what will happen when semaglutide — the active ingredient in Novo Nordisk’s (NVO -17.43%) Ozempic and Wegovy — […]